1. Home
  2. AMGN
  3. AMGN News

Latest Amgen Inc. (AMGN) News on December 21, 2024

Novo Crashes After Obesity Drug Misses Lofty Expectations. Lilly, Viking And Amgen Surge.
AMGN

Investor's Business Daily

11 hours ago

Novo Crashes After Obesity Drug Misses Lofty Expectations. Lilly, Viking And Amgen Surge.

Novo Nordisk Shares Plunge After New Obesity Shot Disappoints
AMGN

The Wall Street Journal

12 hours ago

Novo Nordisk Shares Plunge After New Obesity Shot Disappoints

AMGN

MT Newswires

18 hours ago

Amgen, Eli Lilly, Viking Therapeutics Shares Rise Pre-Bell After Novo Nordisk's Obesity Treatment Falls Short of Expectations

Novo Crashes 20% After New Obesity Drug Misses Forecasts. Lilly, Viking, Amgen Jump.
AMGN

Investor's Business Daily

18 hours ago

Novo Crashes 20% After New Obesity Drug Misses Forecasts. Lilly, Viking, Amgen Jump.

AMGN

MT Newswires

2 days ago

Jefferies Adjusts Amgen Price Target to $350 From $380, Maintains Buy Rating

Why Is Amgen Inc. (AMGN) Among the Best Dividend Stocks to Invest In?
AMGN

Insider Monkey

2 days ago

Why Is Amgen Inc. (AMGN) Among the Best Dividend Stocks to Invest In?

AMGN

Morningstar Research

2 days ago

Analyst Report: Amgen Inc.

Why the Dow is suddenly in a historic funk
AMGN

Yahoo Finance

3 days ago

Why the Dow is suddenly in a historic funk

Amgen (AMGN) Stock Moves -0.21%: What You Should Know
AMGN

Zacks

3 days ago

Amgen (AMGN) Stock Moves -0.21%: What You Should Know

AMGN

MT Newswires

4 days ago

UBS Cuts Price Target on Amgen to $280 From $326, Maintains Neutral Rating

Is Amgen Inc. (AMGN) the Best Weight Loss Stock to Buy Now According to Hedge Funds?
AMGN

Insider Monkey

4 days ago

Is Amgen Inc. (AMGN) the Best Weight Loss Stock to Buy Now According to Hedge Funds?

Viridian Stock Flashes A Bullish Sign In Its Eye-Disease Battle With Amgen
AMGN

Investor's Business Daily

4 days ago

Viridian Stock Flashes A Bullish Sign In Its Eye-Disease Battle With Amgen

Viridian Therapeutics Skyrockets After Besting Amgen In Thyroid Eye Disease
AMGN

Investor's Business Daily

5 days ago

Viridian Therapeutics Skyrockets After Besting Amgen In Thyroid Eye Disease

Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf?
AMGN

Investor's Business Daily

5 days ago

Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf?

How Much Would It Take To Earn $100 A Month From Amgen Stock
AMGN

Benzinga

7 days ago

How Much Would It Take To Earn $100 A Month From Amgen Stock

Amgen to build $1B North Carolina pharmaceutical plant
AMGN

Manufacturing Dive

8 days ago

Amgen to build $1B North Carolina pharmaceutical plant

Why Amgen (AMGN) is a Top Growth Stock for the Long-Term
AMGN

Zacks

9 days ago

Why Amgen (AMGN) is a Top Growth Stock for the Long-Term

Why Amgen Inc. (AMGN) Is the Best Safe Stock to Buy According to Analysts?
AMGN

Insider Monkey

9 days ago

Why Amgen Inc. (AMGN) Is the Best Safe Stock to Buy According to Analysts?

Amgen (AMGN) Stock Sinks As Market Gains: Here's Why
AMGN

Zacks

9 days ago

Amgen (AMGN) Stock Sinks As Market Gains: Here's Why

AMGEN ANNOUNCES 2025 FIRST QUARTER DIVIDEND
AMGN

PR Newswire

10 days ago

AMGEN ANNOUNCES 2025 FIRST QUARTER DIVIDEND

AMGN

Investing.com

11 days ago

BofA reinstates pharma coverage

Here's Why Amgen (AMGN) is a Strong Value Stock
AMGN

Zacks

11 days ago

Here's Why Amgen (AMGN) is a Strong Value Stock

Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
AMGN

Zacks

11 days ago

Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock

AMGN

Argus Research

11 days ago

Daily Spotlight: Biotech Approvals Pick Up

Goldman Sachs adds Burlington, removes Amgen from Conviction List
AMGN

Yahoo Finance Video

12 days ago

Goldman Sachs adds Burlington, removes Amgen from Conviction List

2 No-Brainer Dividend Stocks With Yields Over 3% to Buy in 2025 and Hold for a Decade or Longer
AMGN

Motley Fool

12 days ago

2 No-Brainer Dividend Stocks With Yields Over 3% to Buy in 2025 and Hold for a Decade or Longer

The Zacks Analyst Blog Eli Lilly, Novo Nordisk's Amgen and Viking Therapeutics
AMGN

Zacks

12 days ago

The Zacks Analyst Blog Eli Lilly, Novo Nordisk's Amgen and Viking Therapeutics

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
AMGN

Motley Fool

14 days ago

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?

BLINCYTO® (BLINATUMOMAB) ADDED TO CHEMOTHERAPY SIGNIFICANTLY IMPROVES SURVIVAL IN NEWLY DIAGNOSED PEDIATRIC PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
AMGN

PR Newswire

14 days ago

BLINCYTO® (BLINATUMOMAB) ADDED TO CHEMOTHERAPY SIGNIFICANTLY IMPROVES SURVIVAL IN NEWLY DIAGNOSED PEDIATRIC PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)

AstraZeneca, Daiichi build cancer drug case; Amgen invests $1B
AMGN

BioPharma Dive

15 days ago

AstraZeneca, Daiichi build cancer drug case; Amgen invests $1B

Why Amgen Inc. (AMGN) Is Among the Best Affordable Stocks to Buy Right Now
AMGN

Insider Monkey

15 days ago

Why Amgen Inc. (AMGN) Is Among the Best Affordable Stocks to Buy Right Now

AMGN

MT Newswires

16 days ago

Amgen Expanding in North Carolina With $1 Billion New Manufacturing Site

AMGEN ANNOUNCES $1 BILLION MANUFACTURING EXPANSION IN NORTH CAROLINA
AMGN

PR Newswire

16 days ago

AMGEN ANNOUNCES $1 BILLION MANUFACTURING EXPANSION IN NORTH CAROLINA

Is Amgen Still a Top Dividend Stock?
AMGN

Motley Fool

16 days ago

Is Amgen Still a Top Dividend Stock?

LLY's Zepbound Outshines NVO's Wegovy in Head-to-Head Obesity Study
AMGN

Zacks

16 days ago

LLY's Zepbound Outshines NVO's Wegovy in Head-to-Head Obesity Study

The Zacks Analyst Blog Highlights Amgen, Eaton, Sony, iMage and Enzo Biochem
AMGN

Zacks

16 days ago

The Zacks Analyst Blog Highlights Amgen, Eaton, Sony, iMage and Enzo Biochem

Top Stock Reports for Amgen, Eaton & Enzo Biochem
AMGN

Zacks

16 days ago

Top Stock Reports for Amgen, Eaton & Enzo Biochem

Amgen Stock Falls 12% in a Month: Should You Buy the Dip?
AMGN

Zacks

17 days ago

Amgen Stock Falls 12% in a Month: Should You Buy the Dip?

AMGEN TO PRESENT AT CITI'S 2024 GLOBAL HEALTHCARE CONFERENCE
AMGN

PR Newswire

18 days ago

AMGEN TO PRESENT AT CITI'S 2024 GLOBAL HEALTHCARE CONFERENCE

This Stock Just Dropped by 12% in 1 Day: Should You Buy the Dip?
AMGN

Motley Fool

19 days ago

This Stock Just Dropped by 12% in 1 Day: Should You Buy the Dip?

AMGN

Morningstar Research

19 days ago

Analyst Report: Amgen Inc.

AMGN

MT Newswires

19 days ago

Deutsche Bank Lowers Amgen Price Target to $285 From $305, Maintains Hold Rating

Amgen Inc. (AMGN): A Bull Case Theory
AMGN

Insider Monkey

20 days ago

Amgen Inc. (AMGN): A Bull Case Theory

Eli Lilly and Novo Nordisk’s Obesity Moat Just Got Stronger
AMGN

The Wall Street Journal

21 days ago

Eli Lilly and Novo Nordisk’s Obesity Moat Just Got Stronger

Down 12.3% at One Point in a Single Trading Session, Is Amgen Stock Still a Buy?
AMGN

Motley Fool

21 days ago

Down 12.3% at One Point in a Single Trading Session, Is Amgen Stock Still a Buy?

AMGEN TO PRESENT AT THE 7th ANNUAL EVERCORE HEALTHCONx CONFERENCE
AMGN

PR Newswire

21 days ago

AMGEN TO PRESENT AT THE 7th ANNUAL EVERCORE HEALTHCONx CONFERENCE

Wide Trading Range For Amgen Stock Makes This Option Shine
AMGN

Investor's Business Daily

22 days ago

Wide Trading Range For Amgen Stock Makes This Option Shine

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
AMGN

Zacks

22 days ago

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know

Is Amgen Stock Still a Buy After an Unexpected Reveal of Data?
AMGN

Motley Fool

22 days ago

Is Amgen Stock Still a Buy After an Unexpected Reveal of Data?

Should You Be Excited About Amgen Inc.'s (NASDAQ:AMGN) 56% Return On Equity?
AMGN

Simply Wall St.

23 days ago

Should You Be Excited About Amgen Inc.'s (NASDAQ:AMGN) 56% Return On Equity?

AMGN Stock Down Despite Strong Data From Obesity Drug Study
AMGN

Zacks

23 days ago

AMGN Stock Down Despite Strong Data From Obesity Drug Study

AMGN

MT Newswires

24 days ago

Amgen's Obesity Candidate MariTide Must Mitigate Tolerability Issues to Compete with Blockbuster Tirzepatide, Truist Says

Amgen’s MariTide shows up to 20% average weight loss in Phase 2 study
AMGN

TipRanks

24 days ago

Amgen’s MariTide shows up to 20% average weight loss in Phase 2 study

AMGN

MT Newswires

24 days ago

Leerink Partners Adjusts Price Target on Amgen to $305 From $352, Maintains Market Perform Rating

AMGN

MT Newswires

24 days ago

Redburn Atlantic Adjusts Price Target on Amgen to $195 From $200, Maintains Sell Rating

AMGN

MT Newswires

24 days ago

Deutsche Bank Adjusts Price Target on Amgen to $285 From $305, Maintains Hold Rating

AMGN

MT Newswires

24 days ago

RBC Adjusts Price Target on Amgen to $330 From $360, Maintains Outperform Rating

Why Amgen's Weight Loss Result Is a Win for Eli Lilly
AMGN

Motley Fool

24 days ago

Why Amgen's Weight Loss Result Is a Win for Eli Lilly

Amgen Dives 5% Despite 'Truly Remarkable' Results For Obesity Treatment
AMGN

Investor's Business Daily

24 days ago

Amgen Dives 5% Despite 'Truly Remarkable' Results For Obesity Treatment

Dow Jones, S&P 500 At New High After Fed Minutes; Dell, Workday, CrowdStrike Report (Live Coverage)
AMGN

Investor's Business Daily

24 days ago

Dow Jones, S&P 500 At New High After Fed Minutes; Dell, Workday, CrowdStrike Report (Live Coverage)

Amgen Obesity Drug Falls Short of Efficacy Expectations in Trial, Mizuho Says; Shares Decline
AMGN

MT Newswires

24 days ago

Amgen Obesity Drug Falls Short of Efficacy Expectations in Trial, Mizuho Says; Shares Decline

AMGN

Morningstar Research

24 days ago

Analyst Report: Amgen Inc.

Amgen share price plummets despite Phase II weight loss success
AMGN

Clinical Trials Arena

25 days ago

Amgen share price plummets despite Phase II weight loss success

Amgen Stock Sinks as Obesity Drug Test Results Fail To Meet Expectations
AMGN

Investopedia

25 days ago

Amgen Stock Sinks as Obesity Drug Test Results Fail To Meet Expectations

Amgen Stock Dives After Weight-Loss Drug Data. Here’s What to Know.
AMGN

Barrons.com

25 days ago

Amgen Stock Dives After Weight-Loss Drug Data. Here’s What to Know.

Amgen Crashes 9% Despite 'Truly Remarkable' Results For Obesity Treatment
AMGN

Investor's Business Daily

25 days ago

Amgen Crashes 9% Despite 'Truly Remarkable' Results For Obesity Treatment

Amgen says its Ozempic competitor helped patients lose 20% of their weight. Wall Street isn't impressed
AMGN

Quartz

25 days ago

Amgen says its Ozempic competitor helped patients lose 20% of their weight. Wall Street isn't impressed

Amgen Crashes After Weight-Loss Drug Only Meets Eli Lilly's Zepbound
AMGN

Investor's Business Daily

25 days ago

Amgen Crashes After Weight-Loss Drug Only Meets Eli Lilly's Zepbound

Amgen shows 20% weight loss in once-monthly injectable MariTide
AMGN

Yahoo Finance

25 days ago

Amgen shows 20% weight loss in once-monthly injectable MariTide

AMGN

MT Newswires

25 days ago

Sector Update: Health Care Stocks Mixed Premarket Tuesday

AMGN

MT Newswires

25 days ago

Update: Amgen Says Phase 2 Study Shows MariTide Achieves up to 20% Weight Loss in One Year

Amgen Reveals Data From Closely Watched Monthly Obesity Drug, With Weight Loss Of Up To 20% At One Year And No Plateau
AMGN

Benzinga

25 days ago

Amgen Reveals Data From Closely Watched Monthly Obesity Drug, With Weight Loss Of Up To 20% At One Year And No Plateau

AMGN

MT Newswires

25 days ago

Citigroup Adjusts Price Target on Amgen to $310 From $335, Neutral Rating Maintained

Amgen Stock Dives Despite Positive Weight-Loss Drug Data. What to Know.
AMGN

Barrons.com

25 days ago

Amgen Stock Dives Despite Positive Weight-Loss Drug Data. What to Know.

AMGN

Investing.com

25 days ago

Amgen falls after obesity study results

AMGN

MT Newswires

a month ago

RBC Cuts Price Target on Amgen to $360 From $362, Maintains Outperform Rating

Is There An Opportunity With Amgen Inc.'s (NASDAQ:AMGN) 49% Undervaluation?
AMGN

Simply Wall St.

a month ago

Is There An Opportunity With Amgen Inc.'s (NASDAQ:AMGN) 49% Undervaluation?

RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried?
AMGN

Investor's Business Daily

a month ago

RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried?

Why Amgen (AMGN) is a Top Value Stock for the Long-Term
AMGN

Zacks

a month ago

Why Amgen (AMGN) is a Top Value Stock for the Long-Term

Analysis-Wall Street awaits Amgen weight-loss drug data expected to move shares
AMGN

Reuters

a month ago

Analysis-Wall Street awaits Amgen weight-loss drug data expected to move shares

Amgen picks prolific biotech founder Chang as new top scientist
AMGN

BioPharma Dive

a month ago

Amgen picks prolific biotech founder Chang as new top scientist

Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop
AMGN

Barrons.com

a month ago

Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop

AMGEN ANNOUNCES SENIOR EXECUTIVE RESEARCH APPOINTMENT
AMGN

PR Newswire

a month ago

AMGEN ANNOUNCES SENIOR EXECUTIVE RESEARCH APPOINTMENT

SLN Stock Down Despite Cholesterol Drug Lowering Lipoprotein Levels
AMGN

Zacks

a month ago

SLN Stock Down Despite Cholesterol Drug Lowering Lipoprotein Levels

Amgen Stock Has High Implied Volatility. An Iron Condor Takes Advantage.
AMGN

Investor's Business Daily

a month ago

Amgen Stock Has High Implied Volatility. An Iron Condor Takes Advantage.

Is Amgen Inc. (AMGN) the Best Immunotherapy Stock to Buy Now?
AMGN

Insider Monkey

a month ago

Is Amgen Inc. (AMGN) the Best Immunotherapy Stock to Buy Now?

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
AMGN

Zacks

a month ago

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

AMGN

Morningstar Research

a month ago

Analyst Report: Amgen Inc.

The weight-loss frenzy is making some pharma stocks much more volatile. Will the drama continue?
AMGN

Yahoo Finance

a month ago

The weight-loss frenzy is making some pharma stocks much more volatile. Will the drama continue?

2 Reasons to Buy Amgen Stock, and 1 Reason to Be Cautious
AMGN

Motley Fool

a month ago

2 Reasons to Buy Amgen Stock, and 1 Reason to Be Cautious

The three-year decline in earnings for Amgen NASDAQ:AMGN) isn't encouraging, but shareholders are still up 50% over that period
AMGN

Simply Wall St.

a month ago

The three-year decline in earnings for Amgen NASDAQ:AMGN) isn't encouraging, but shareholders are still up 50% over that period

AMGEN PRESENTS NEW DATA ACROSS RARE INFLAMMATORY DISEASES AT ACR 2024
AMGN

PR Newswire

a month ago

AMGEN PRESENTS NEW DATA ACROSS RARE INFLAMMATORY DISEASES AT ACR 2024

Amgen Shrugs Off Bone Density Concerns Related to Obesity Candidate
AMGN

Zacks

a month ago

Amgen Shrugs Off Bone Density Concerns Related to Obesity Candidate

5 Healthcare Stocks to Buy in a Beaten-Up Sector
AMGN

Barrons.com

a month ago

5 Healthcare Stocks to Buy in a Beaten-Up Sector

2 Dividend Stocks to Buy Hand Over Fist in November
AMGN

Motley Fool

a month ago

2 Dividend Stocks to Buy Hand Over Fist in November

AMGN

Investing.com

a month ago

Citi initiates coverage on 5 new biotech stocks

Amgen speaks out about bone density concerns with obesity drug
AMGN

Clinical Trials Arena

a month ago

Amgen speaks out about bone density concerns with obesity drug

Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand?
AMGN

Investor's Business Daily

a month ago

Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand?

Amgen Defends Its Investigational Monthly Weight Loss Injection After Analyst Cites MariTide's Impact on Bone Density
AMGN

Benzinga

a month ago

Amgen Defends Its Investigational Monthly Weight Loss Injection After Analyst Cites MariTide's Impact on Bone Density

AMGN

MT Newswires

a month ago

HSBC Adjusts Price Target on Amgen to $385 From $369

Share on Social Networks: